Horizon Pharma (HZNP) Tops Q4 EPS by 5c; Boosts FY15 Outlook
Get Alerts HZNP Hot Sheet
Join SI Premium – FREE
Horizon Pharma (NASDAQ: HZNP) reported Q4 EPS of $0.27, $0.05 better than the analyst estimate of $0.22. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $95.5 million.
2015 Guidance
The Company today announced it is raising 2015 full year guidance as follows:
Prior Guidance New Guidance
-------------------- --------------------
Net sales $425 to $450 million $450 to $475 million
Adjusted EBITDA $160 to $180 million $170 to $190 million
For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Plexus Corp (PLXS) Tops Q2 EPS by 7c
- St. Joe Company (JOE) Reports Q1 EPS of $0.24
- First Internet Bancorp (INBK) Tops Q1 EPS by 5c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!